ID   CSK22_HUMAN             Reviewed;         350 AA.
AC   P19784;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   05-OCT-2010, entry version 113.
DE   RecName: Full=Casein kinase II subunit alpha';
DE            Short=CK II alpha';
DE            EC=2.7.11.1;
GN   Name=CSNK2A2; Synonyms=CK2A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=91070071; PubMed=2174700; DOI=10.1021/bi00488a034;
RA   Lozeman F.J., Litchfield D.W., Piening C., Takio K., Walsh K.A.,
RA   Krebs E.G.;
RT   "Isolation and characterization of human cDNA clones encoding the
RT   alpha and the alpha' subunits of casein kinase II.";
RL   Biochemistry 29:8436-8447(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH SSRP1 AND SUPT16H.
RX   PubMed=11239457; DOI=10.1016/S1097-2765(01)00176-9;
RA   Keller D.M., Zeng X., Wang Y., Zhang Q.H., Kapoor M., Shu H.,
RA   Goodman R., Lozano G., Zhao Y., Lu H.;
RT   "A DNA damage-induced p53 serine 392 kinase complex contains CK2,
RT   hSpt16, and SSRP1.";
RL   Mol. Cell 7:283-292(2001).
RN   [4]
RP   INTERACTION WITH SSRP1 AND SUPT16H.
RX   PubMed=12393879; DOI=10.1074/jbc.M209820200;
RA   Keller D.M., Lu H.;
RT   "p53 serine 392 phosphorylation increases after UV through induction
RT   of the assembly of the CK2.hSPT16.SSRP1 complex.";
RL   J. Biol. Chem. 277:50206-50213(2002).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-21 AND SER-288,
RP   AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-13; SER-18; SER-21;
RP   TYR-240; SER-288 AND SER-343, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-97, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-188.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Casein kinases are operationally defined by their
CC       preferential utilization of acidic proteins such as caseins as
CC       substrates. The alpha and alpha' chains contain the catalytic
CC       site. Participates in Wnt signaling. CK2 phosphorylates 'Ser-392'
CC       of p53/TP53 following UV irradiation.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Tetramer composed of an alpha chain, an alpha' and two
CC       beta chains. Also component of a CK2-SPT16-SSRP1 complex composed
CC       of SSRP1, SUPT16H, CSNK2A1, CSNK2A2 and CSNK2B, the complex
CC       associating following UV irradiation.
CC   -!- INTERACTION:
CC       P67870:CSNK2B; NbExp=3; IntAct=EBI-347451, EBI-348169;
CC       O60282:KIF5C; NbExp=2; IntAct=EBI-347451, EBI-717170;
CC       Q15287:RNPS1; NbExp=1; IntAct=EBI-347451, EBI-395959;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. CK2 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M55268; AAA51548.1; -; mRNA.
DR   EMBL; BC008812; AAH08812.1; -; mRNA.
DR   IPI; IPI00020602; -.
DR   PIR; B35838; B35838.
DR   RefSeq; NP_001887.1; -.
DR   UniGene; Hs.82201; -.
DR   PDB; 3E3B; X-ray; 3.20 A; X=1-334.
DR   PDBsum; 3E3B; -.
DR   ProteinModelPortal; P19784; -.
DR   DIP; DIP-318N; -.
DR   IntAct; P19784; 22.
DR   MINT; MINT-5004107; -.
DR   STRING; P19784; -.
DR   PhosphoSite; P19784; -.
DR   SWISS-2DPAGE; P19784; -.
DR   PeptideAtlas; P19784; -.
DR   PRIDE; P19784; -.
DR   Ensembl; ENST00000262506; ENSP00000262506; ENSG00000070770.
DR   GeneID; 1459; -.
DR   KEGG; hsa:1459; -.
DR   UCSC; uc002enc.1; human.
DR   CTD; 1459; -.
DR   GeneCards; GC16M058191; -.
DR   H-InvDB; HIX0013086; -.
DR   HGNC; HGNC:2459; CSNK2A2.
DR   MIM; 115442; gene.
DR   PharmGKB; PA26959; -.
DR   eggNOG; prNOG16169; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG107282; -.
DR   InParanoid; P19784; -.
DR   OMA; PSWGNQD; -.
DR   OrthoDB; EOG9GF60S; -.
DR   PhylomeDB; P19784; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; nfkappabatypicalpathway; Atypical NF-kappaB pathway.
DR   Pathway_Interaction_DB; p38alphabetadownstreampathway; Signaling mediated by p38-alpha and p38-beta.
DR   Reactome; REACT_18266; Axon guidance.
DR   NextBio; 5997; -.
DR   ArrayExpress; P19784; -.
DR   Bgee; P19784; -.
DR   CleanEx; HS_CSNK2A2; -.
DR   Genevestigator; P19784; -.
DR   GermOnline; ENSG00000070770; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0016055; P:Wnt receptor signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase; Wnt signaling pathway.
FT   CHAIN         1    350       Casein kinase II subunit alpha'.
FT                                /FTId=PRO_0000085891.
FT   DOMAIN       40    325       Protein kinase.
FT   NP_BIND      46     54       ATP (By similarity).
FT   ACT_SITE    157    157       Proton acceptor (By similarity).
FT   BINDING      69     69       ATP (By similarity).
FT   MOD_RES      13     13       Phosphotyrosine.
FT   MOD_RES      18     18       Phosphoserine.
FT   MOD_RES      21     21       Phosphoserine.
FT   MOD_RES      97     97       N6-acetyllysine.
FT   MOD_RES     240    240       Phosphotyrosine.
FT   MOD_RES     288    288       Phosphoserine.
FT   MOD_RES     343    343       Phosphoserine.
FT   VARIANT     188    188       E -> A (in dbSNP:rs55911801).
FT                                /FTId=VAR_040416.
FT   STRAND       11     13
FT   TURN         14     18
FT   HELIX        22     25
FT   STRAND       40     45
FT   STRAND       53     59
FT   HELIX        60     62
FT   STRAND       64     70
FT   HELIX        76     87
FT   STRAND       98    103
FT   TURN        105    107
FT   STRAND      110    114
FT   HELIX       122    125
FT   HELIX       132    150
FT   HELIX       160    162
FT   STRAND      163    166
FT   TURN        167    170
FT   STRAND      171    174
FT   TURN        196    198
FT   TURN        202    206
FT   HELIX       213    218
FT   HELIX       222    228
FT   HELIX       241    247
FT   TURN        253    255
FT   TURN        259    263
FT   HELIX       270    273
FT   HELIX       282    285
FT   HELIX       288    290
FT   TURN        291    293
FT   HELIX       296    305
FT   STRAND      308    313
FT   HELIX       316    320
FT   HELIX       323    325
FT   TURN        330    332
SQ   SEQUENCE   350 AA;  41213 MW;  3ECB92F6BD3DD7F1 CRC64;
     MPGPAAGSRA RVYAEVNSLR SREYWDYEAH VPSWGNQDDY QLVRKLGRGK YSEVFEAINI
     TNNERVVVKI LKPVKKKKIK REVKILENLR GGTNIIKLID TVKDPVSKTP ALVFEYINNT
     DFKQLYQILT DFDIRFYMYE LLKALDYCHS KGIMHRDVKP HNVMIDHQQK KLRLIDWGLA
     EFYHPAQEYN VRVASRYFKG PELLVDYQMY DYSLDMWSLG CMLASMIFRR EPFFHGQDNY
     DQLVRIAKVL GTEELYGYLK KYHIDLDPHF NDILGQHSRK RWENFIHSEN RHLVSPEALD
     LLDKLLRYDH QQRLTAKEAM EHPYFYPVVK EQSQPCADNA VLSSGLTAAR
//
